Mylan Ruling Cements Del., NJ As Top ANDA Venues
The Federal Circuit's decision that generic-drug makers can be sued for patent infringement wherever they plan to make sales resolves confusion about venue caused by a recent U.S. Supreme Court ruling...To view the full article, register now.
Already a subscriber? Click here to view full article